New York City Council Header
File #: Int 0669-2018    Version: Name: Requiring the municipal drug strategy advisory council to report on opioid antagonist distribution.
Type: Introduction Status: Enacted
Committee: Committee on Mental Health, Disabilities and Addiction
On agenda: 3/7/2018
Enactment date: 6/26/2018 Law number: 2018/129
Title: A Local Law to amend the charter of the city of New York, in relation to requiring the municipal drug strategy advisory council to report on opioid antagonist distribution
Sponsors: Ritchie J. Torres, Robert F. Holden, Stephen T. Levin, Ben Kallos, Carlina Rivera
Council Member Sponsors: 5
Summary: This bill would require the would require the Municipal Drug Strategy Advisory Council, a council established by Local Law 48 of 2017 and comprised of health care professionals, advocates, and persons suffering from substance misuse disorder, to include in its biennial report the number of opioid overdose reversal drugs that are distributed to City agencies.
Indexes: Report Required
Attachments: 1. Summary of Int. No. 669-A, 2. Summary of Int. No. 669, 3. Int. No. 669, 4. Committee Report 2/27/18, 5. Hearing Testimony 2/27/18, 6. Hearing Testimony 2/27/18 (Con't), 7. Hearing Transcript 2/27/18, 8. March 7, 2018 - Stated Meeting Agenda, 9. Proposed Int. No. 669-A - 6/1/18, 10. Committee Report 6/5/18, 11. Hearing Transcript 6/5/18, 12. Hearing Transcript - Stated Meeting 6-7-18, 13. Minutes of the Recessed Stated Meeting - June 7, 2018, 14. Fiscal Impact Statement, 15. Int. No. 669-A (FINAL), 16. Local Law 129, 17. Minutes of the Stated Meeting - June 7, 2018
Date Ver.Prime SponsorAction ByActionResultAction DetailsMeeting DetailsMultimedia
6/27/2018ARitchie J. Torres City Council Recved from Mayor by Council  Action details Meeting details Not available
6/26/2018ARitchie J. Torres Mayor Signed Into Law by Mayor  Action details Meeting details Not available
6/26/2018ARitchie J. Torres Mayor Hearing Held by Mayor  Action details Meeting details Not available
6/7/2018ARitchie J. Torres City Council Sent to Mayor by Council  Action details Meeting details Not available
6/7/2018ARitchie J. Torres City Council Approved by CouncilPass Action details Meeting details Not available
6/5/2018*Ritchie J. Torres Committee on Mental Health, Disabilities and Addiction Hearing Held by Committee  Action details Meeting details Not available
6/5/2018*Ritchie J. Torres Committee on Mental Health, Disabilities and Addiction Amendment Proposed by Comm  Action details Meeting details Not available
6/5/2018*Ritchie J. Torres Committee on Mental Health, Disabilities and Addiction Amended by Committee  Action details Meeting details Not available
6/5/2018ARitchie J. Torres Committee on Mental Health, Disabilities and Addiction Approved by CommitteePass Action details Meeting details Not available
3/7/2018*Ritchie J. Torres City Council Referred to Comm by Council  Action details Meeting details Not available
3/7/2018*Ritchie J. Torres City Council Introduced by Council  Action details Meeting details Not available
2/27/2018*Ritchie J. Torres Committee on General Welfare P-C Item Laid Over by Comm  Action details Meeting details Not available
2/27/2018*Ritchie J. Torres Committee on General Welfare Hearing on P-C Item by Comm  Action details Meeting details Not available
2/27/2018*Ritchie J. Torres Committee on Mental Health, Disabilities and Addiction P-C Item Laid Over by Comm  Action details Meeting details Not available
2/27/2018*Ritchie J. Torres Committee on Mental Health, Disabilities and Addiction Hearing on P-C Item by Comm  Action details Meeting details Not available

Int. No. 669-A

 

By Council Members Torres, Holden, Levin, Kallos and Rivera

 

A Local Law to amend the charter of the city of New York, in relation to requiring the municipal drug strategy advisory council to report on opioid antagonist distribution

 

Be it enacted by the Council as follows:

 

Section 1. Subdivision b of section 20-c of the New York city charter, as added by local law number 48 for the year 2017, is amended to read as follows:

b. No later than February 1, 2018, and no later than February 1 biennially thereafter, the designated agency shall prepare and submit to the mayor and the speaker of the city council a report on municipal drug strategy. The department shall consult with relevant stakeholders, including but not limited to community-based harm reduction programs, licensed substance use disorder treatment programs, healthcare providers, prevention programs, drug policy reform organizations, community-based criminal justice programs, persons directly affected by drug use, persons formerly incarcerated for drug related offenses, and experts in issues related to illicit and non-medical drug use and policies, in preparing the report. Such report shall include, but not be limited to:

1. A summary of current drug policies, programs, and services in the city, including an overview of goals to address the use of illicit and non-medical drugs such as the use of prescription drugs for non-prescription purposes;

2. A summary of interventions needed in order to reduce drug-related disease, mortality, and crime, and any inequities and disparities related to race, ethnicity, age, income, gender, geography, and immigration status;

3. An overview of programs, legislation or administrative action to promote and support health and wellness related to drug use, as well as to improve the public health and safety of the city's individuals, families, and communities by addressing the health, social and economic problems associated with illicit and non-medical drug use, past or current drug policies, and to reduce any stigma associated with drug use;

4. An overview of the city's efforts to collaborate with existing substance use, medical, and mental health services, including community-based harm reduction programs, licensed substance use disorder treatment programs, healthcare providers, formalized recovery support programs, youth prevention programs, drug policy reform programs and community-based criminal justice programs to develop and foster effective responses to illicit and non-medical drug use in the city;

5. An overview of pilot programs related to illicit and non-medical drug use; [and]

6. An overview of any other proposals to achieve the city-wide goals and objectives related to illicit and non-medical drug use, including, if available, timelines for implementation; and

7. Data on the projected number of opioid antagonists needed by all relevant city agencies, the actual number of opioid antagonists distributed to all relevant city agencies and the number of opioid antagonists distributed to registered opioid overdose prevention programs citywide.

§ 2. This local law takes effect immediately, and shall expire and be deemed repealed on the same date local law number 48 for the year 2017 expires and is deemed repealed.

 

SSY

LS # 4880

5/30/2018 7:33 pm